187 related articles for article (PubMed ID: 15705277)
1. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Manavi K; Young H; McMillan A
Int J STD AIDS; 2005 Jan; 16(1):68-70. PubMed ID: 15705277
[TBL] [Abstract][Full Text] [Related]
2. Oropharyngeal gonorrhoea: rate of co-infection with sexually transmitted infection, antibiotic susceptibility and treatment outcome.
Manavi K; Zafar F; Shahid H
Int J STD AIDS; 2010 Feb; 21(2):138-40. PubMed ID: 19884359
[TBL] [Abstract][Full Text] [Related]
3. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
Harry TC
Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
[No Abstract] [Full Text] [Related]
4. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
Hustig A; Bell C; Waddell R
Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
[TBL] [Abstract][Full Text] [Related]
5. Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.
Hananta IPY; De Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
Sex Transm Infect; 2017 Nov; 93(7):467-471. PubMed ID: 28822976
[TBL] [Abstract][Full Text] [Related]
6. Single-dose therapy of anogenital and pharyngeal gonorrhoea with ciprofloxacin.
Balachandran T; Roberts AP; Evans BA; Azadian BS
Int J STD AIDS; 1992; 3(1):49-51. PubMed ID: 1543768
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
Unemo M; Golparian D; Hestner A
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
[TBL] [Abstract][Full Text] [Related]
8. Challenges in implementing the new BASHH guidelines for the management of gonorrhoea.
Rodgers S; Murgatroyd M; Perez K; Kingston M; Lee V
Int J STD AIDS; 2014 Feb; 25(2):145-7. PubMed ID: 23970641
[TBL] [Abstract][Full Text] [Related]
9. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
Unemo M; Golparian D; Potočnik M; Jeverica S
Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin versus amoxycillin and probenecid in the treatment of uncomplicated gonorrhoea.
Lassus A; Karppinen L; Ingervo L; Jeskanen L; Reitamo S; Happonen HP; Karkulahti R
Scand J Infect Dis Suppl; 1989; 60():58-61. PubMed ID: 2502837
[TBL] [Abstract][Full Text] [Related]
11. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
Y Chen M; Stevens K; Tideman R; Zaia A; Tomita T; Fairley CK; Lahra M; Whiley D; Hogg G
J Antimicrob Chemother; 2013 Jun; 68(6):1445-7. PubMed ID: 23390207
[No Abstract] [Full Text] [Related]
12. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study.
Ota KV; Fisman DN; Tamari IE; Smieja M; Ng LK; Jones KE; Diprima A; Richardson SE
Clin Infect Dis; 2009 May; 48(9):1237-43. PubMed ID: 19323630
[TBL] [Abstract][Full Text] [Related]
13. Appropriate time for test-of-cure when diagnosing gonorrhoea with a nucleic acid amplification test.
Hjelmevoll SO; Olsen ME; Sollid JU; Haaheim H; Melby KK; Moi H; Unemo M; Skogen V
Acta Derm Venereol; 2012 May; 92(3):316-9. PubMed ID: 22286973
[TBL] [Abstract][Full Text] [Related]
14. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
[TBL] [Abstract][Full Text] [Related]
15. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
[TBL] [Abstract][Full Text] [Related]
16. Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?
Lewis DA
Sex Transm Infect; 2015 Jun; 91(4):234-7. PubMed ID: 25911525
[TBL] [Abstract][Full Text] [Related]
17. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada.
Gratrix J; Bergman J; Egan C; Drews SJ; Read R; Singh AE
Sex Transm Dis; 2013 Nov; 40(11):877-9. PubMed ID: 24113412
[TBL] [Abstract][Full Text] [Related]
18. Could antiseptic mouthwash inhibit pharyngeal
Chow EPF; Fairley CK
Sex Transm Infect; 2017 Sep; 93(6):403. PubMed ID: 28827305
[No Abstract] [Full Text] [Related]
19. Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhoea in men.
Scott GR; McMillan A; Young H
J Antimicrob Chemother; 1987 Jul; 20(1):117-21. PubMed ID: 3624110
[TBL] [Abstract][Full Text] [Related]
20. [Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].
Koedijk FD; van den Broek I; Stirbu-Wagner I; van Bergen JE
Ned Tijdschr Geneeskd; 2013; 157(24):A5642. PubMed ID: 23759175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
